Biological Response Modifiers as Therapies for AIDS

McGowan, John J.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Research and Development Contracts (N01)
• Project #: N01AI072662-001
• Application #: 3596210
• Project Start: 1987-09-01
• Project End: 1992-08-31
• Budget Start: 1988-01-28
• Budget End: 1988-08-31
• Fiscal Year: 1988

Institution

• Name: Utah State University
• Type: Earth Sciences/Resources
• City: Logan
• State: UT
• Country: United States
• Zip Code: 84322

Publications

Morrey, J D; Jackson, M K; Bunch, T D et al. (1993) Activation of the human immunodeficiency virus type 1 long terminal repeat by skin-sensitizing chemicals in transgenic mice. Intervirology 36:65-71

Mead, J R; Burger, R A; Morrey, J D et al. (1993) Effect of immunomodulators in the hu-PBL-SCID mouse model. Biotechnol Ther 4:133-43

Morrey, J D; Warren, R P; Okleberry, K M et al. (1991) Effect of imexon treatment on Friend virus complex infection using genetically defined mice as a model for HIV-1 infection. Antiviral Res 15:51-65

Morrey, J D; Bourn, S M; Bunch, T D et al. (1991) In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J Virol 65:5045-51

Morrey, J D; Warren, R P; Okleberry, K M et al. (1990) Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection. J Acquir Immune Defic Syndr 3:500-10